A new exploratory agent has been tested in the treatment of the hepatitis C virus infection (HCV), allowing patients to avoid the current interferon treatment that comes with harsh side effects. The drug is sofosbuvir, an oral nucleotide inhibitor of the viral polymerase. MNT
No comments:
Post a Comment